本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Edgewise Therapeutics, Inc.

13.45
+0.42003.22%
盤後13.450.00000.00%16:32 EDT
成交量:99.08萬
成交額:1,320.40萬
市值:14.14億
市盈率:-9.29
高:13.58
開:12.98
低:12.61
收:13.03
資料載入中...
2025/04/02

重要事件披露

Form 8-K - Current report
2025/04/02

重要事件披露

Form 8-K - Current report
2025/03/04

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2025/03/03

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2025/03/03

重要事件披露

Form 8-K - Current report
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/02/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/22

重要事件披露

Form 8-K - Current report
2024/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/26

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/16

重要事件披露

Form 8-K - Current report
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/11/07

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]